France ' s Neovacs Takes on GSK and AstraZeneca in Battle to Treat Lupus France ' s Neovacs Takes on GSK and AstraZeneca in Battle to Treat Lupus

French biotech company Neovacs is confident that its experimental drug to treat lupus could grab significant market share from standard treatments of the autoimmune disease, its chief executive said.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news